October 29, 2025.
Aditxt, Inc. (NASDAQ: ADTX) will effect a 1-for-113 reverse split of its common stock, beginning November 3, 2025, on the Nasdaq Capital Market under the symbol ADTX. The reverse stock split was approved by the Company’s stockholders on September 23, 2025, with the final ratio determined by the board of directors.
As a result, the CUSIP number for the Company’s common stock will now be 007025885. Every 113 shares of issued and outstanding common stock will be exchanged for 1 share of common stock, with any fractional shares rounded up. Immediately after, the Company will have approximately 501,401 shares of common stock issued and outstanding.
Adjustments will also be made to the Company’s outstanding warrants and stock options, and the reverse stock split is primarily intended to bring the Company into compliance with Nasdaq’s minimum bid price requirement. Additional information can be found in Aditxt’s proxy statement filed with the SEC on August 8, 2025.
Aditxt, Inc.® is a social innovation platform accelerating promising health innovations, collaboratively driving their mission to “Make Promising Innovations Possible Together.”
Certain statements in this press release constitute forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors and risks more fully discussed in Aditxt’s most recent Annual Report on Form 10-K, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, except as required by law.
Source: Aditxt, Inc.
